{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:52:46Z","timestamp":1791478366069,"version":"4.3.4"},"reference-count":50,"publisher":"American Chemical Society (ACS)","issue":"19","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA023168"],"award-info":[{"award-number":["P30CA023168"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["RO1CA069202"],"award-info":[{"award-number":["RO1CA069202"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006377","name":"Purdue University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006377","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Protein tyrosine phosphatase 1B (PTP1B) and T cell protein tyrosine phosphatase (TCPTP) play non-redundant roles in regulating T cell activation and tumor antigen presentation, making them compelling cancer immunotherapy targets. Recent studies have illustrated the viability of concomitant PTP1B\/TCPTP degradation as a promising strategy to drug these proteins. Herein, using a phosphonodifluoromethyl phenylalanine (F2Pmp)-based dual PTP1B and TCPTP inhibitor, we report a cereblon (CRBN)-based small molecule degrader X1 targeting both phosphatases with improved potency, selectivity, and plasma exposure after intraperitoneal administration. X1 enhances T cell receptor (TCR) signaling in T cells and IFN\u03b3-mediated JAK1\/2-STAT1 activation in tumor cells, promoting surface MHC-I antigen presentation. X1 alone or combined with anti-PD-1 treatment exhibits robust anti-tumor efficacy in a syngeneic tumor model by increasing T cell infiltration and activation. These findings highlight the translational potential of systemic and concomitant targeting of both PTP1B and TCPTP as a promising strategy for cancer immunotherapy.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.6c01484","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:01:31Z","timestamp":1790103691000},"page":"22336-22354","source":"Crossref","is-referenced-by-count":0,"title":["Discovery and Characterization of a Cereblon-Based Degrader for PTP1B and TCPTP"],"prefix":"10.1021","volume":"69","author":[{"given":"Zihan","family":"Qu","sequence":"first","affiliation":[{"name":"Purdue University , , , ,","place":["West Lafayette, Indiana, United States, 47907"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunpeng","family":"Bai","sequence":"additional","affiliation":[{"name":"Purdue University , , , ,","place":["West Lafayette, Indiana, United States, 47907"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmin","family":"Miao","sequence":"additional","affiliation":[{"name":"Purdue University , , , ,","place":["West Lafayette, Indiana, United States, 47907"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Dong","sequence":"additional","affiliation":[{"name":"Purdue University , , , ,","place":["West Lafayette, Indiana, United States, 47907"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9190-8900","authenticated-orcid":true,"given":"Zheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Purdue University , , , ,","place":["West Lafayette, Indiana, United States, 47907"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Miao","sequence":"additional","affiliation":[{"name":"Purdue University , , , ,","place":["West Lafayette, Indiana, United States, 47907"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick Nguele","family":"Meke","sequence":"additional","affiliation":[{"name":"Purdue University , , , ,","place":["West Lafayette, Indiana, United States, 47907"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8188-9056","authenticated-orcid":true,"given":"Benjamin","family":"Babalola","sequence":"additional","affiliation":[{"name":"Purdue University , , , ,","place":["West Lafayette, Indiana, United States, 47907"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momen","family":"Al-Hindy","sequence":"additional","affiliation":[{"name":"Purdue University , , , ,","place":["West Lafayette, Indiana, United States, 47907"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Huang","sequence":"additional","affiliation":[{"name":"Purdue University , , , ,","place":["West Lafayette, Indiana, United States, 47907"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1826-6902","authenticated-orcid":true,"given":"Jingmei","family":"Yu","sequence":"additional","affiliation":[{"name":"Purdue University , , , ,","place":["West Lafayette, Indiana, United States, 47907"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5535-5517","authenticated-orcid":true,"given":"W. Andy","family":"Tao","sequence":"additional","affiliation":[{"name":"Purdue University , , , ,","place":["West Lafayette, Indiana, United States, 47907"]},{"name":"Purdue University , , , ,","place":["West Lafayette, Indiana, United States, 47907"]},{"name":"Purdue University , , , ,","place":["West Lafayette, Indiana, United States, 47907"]},{"name":"Purdue University , , , ,","place":["West Lafayette, Indiana, United States, 47907"]},{"name":"Purdue University , , 720 Clinic Drive , , ,","place":["West Lafayette, Indiana, United States, 47907"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5527-7910","authenticated-orcid":true,"given":"Zhong-Yin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Purdue University , , , ,","place":["West Lafayette, Indiana, United States, 47907"]},{"name":"Purdue University , , , ,","place":["West Lafayette, Indiana, United States, 47907"]},{"name":"Purdue University , , , ,","place":["West Lafayette, Indiana, United States, 47907"]},{"name":"Purdue University , , , ,","place":["West Lafayette, Indiana, United States, 47907"]},{"name":"Purdue University , , 720 Clinic Drive , , ,","place":["West Lafayette, Indiana, United States, 47907"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"issue":"3","key":"2026100811084111400_cit1","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1021\/acs.chemrev.7b00105","article-title":"Regulatory Mechanisms and Novel Therapeutic Targeting Strategies for Protein Tyrosine Phosphatases","volume":"118","author":"Yu","year":"2018","journal-title":"Chem. Rev."},{"issue":"11","key":"2026100811084111400_cit2","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/s41573-021-00252-y","article-title":"Trends in kinase drug discovery: targets, indications and inhibitor design","volume":"20","author":"Attwood","year":"2021","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"1","key":"2026100811084111400_cit3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1021\/acs.accounts.6b00537","article-title":"Drugging the Undruggable: Therapeutic Potential of Targeting Protein Tyrosine Phosphatases","volume":"50","author":"Zhang","year":"2017","journal-title":"Acc. Chem. Res."},{"issue":"4","key":"2026100811084111400_cit4","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1042\/BST20201308","article-title":"Functional interrogation and therapeutic targeting of protein tyrosine phosphatases","volume":"49","author":"Krabill","year":"2021","journal-title":"Biochem. Soc. Trans."},{"issue":"7664","key":"2026100811084111400_cit5","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nature23270","article-title":"In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target","volume":"547","author":"Manguso","year":"2017","journal-title":"Nature"},{"issue":"7984","key":"2026100811084111400_cit6","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/s41586-023-06575-7","article-title":"The PTPN2\/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity","volume":"622","author":"Baumgartner","year":"2023","journal-title":"Nature"},{"issue":"1","key":"2026100811084111400_cit7","doi-asserted-by":"publisher","first-page":"4524","DOI":"10.1038\/s41467-023-40170-8","article-title":"A small molecule inhibitor of PTP1B and PTPN2 enhances T cell anti-tumor immunity","volume":"14","author":"Liang","year":"2023","journal-title":"Nat. Commun."},{"issue":"22","key":"2026100811084111400_cit8","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202303818","article-title":"Small Molecule Degraders of Protein Tyrosine Phosphatase 1B and T cell Protein Tyrosine Phosphatase for Cancer Immunotherapy","volume":"62","author":"Dong","year":"2023","journal-title":"Angew Chem Int Ed."},{"issue":"2","key":"2026100811084111400_cit9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1517\/13543784.12.2.223","article-title":"PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity","volume":"12","author":"Zhang","year":"2003","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"2","key":"2026100811084111400_cit10","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1128\/mcb.25.2.819-829.2005","article-title":"Coordinated regulation of insulin signaling by the protein tyrosine phosphatases PTP1B and TCPTP","volume":"25","author":"Galic","year":"2005","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"2026100811084111400_cit11","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1742-4658.2012.08563.x","article-title":"PTP1B and TCPTP--nonredundant phosphatases in insulin signaling and glucose homeostasis","volume":"280","author":"Tiganis","year":"2013","journal-title":"The FEBS journal"},{"issue":"21","key":"2026100811084111400_cit12","doi-asserted-by":"publisher","first-page":"7117","DOI":"10.1128\/MCB.21.21.7117-7136.2001","article-title":"Structural and evolutionary relationships among protein tyrosine phosphatase domains","volume":"21","author":"Andersen","year":"2001","journal-title":"Mol. Cell. Biol."},{"issue":"5407","key":"2026100811084111400_cit13","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1126\/science.283.5407.1544","article-title":"Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene","volume":"283","author":"Elchebly","year":"1999","journal-title":"Science"},{"issue":"51","key":"2026100811084111400_cit14","doi-asserted-by":"publisher","first-page":"47771","DOI":"10.1074\/jbc.C100583200","article-title":"TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B","volume":"276","author":"Myers","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"23","key":"2026100811084111400_cit15","doi-asserted-by":"publisher","first-page":"9368","DOI":"10.1073\/pnas.0812109106","article-title":"Protein tyrosine phosphatases PTP-1B and TC-PTP play nonredundant roles in macrophage development and IFN-gamma signaling","volume":"106","author":"Heinonen","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"8","key":"2026100811084111400_cit16","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abk3338","article-title":"PTPN2 Elicits Cell Autonomous and Non\u2212Cell Autonomous Effects on Antitumor Immunity in Triple-Negative Breast Cancer","volume":"8","author":"Goh","year":"2022","journal-title":"Sci. Adv."},{"issue":"37","key":"2026100811084111400_cit17","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.1038\/s41388-018-0337-6","article-title":"Myeloid-restricted ablation of Shp2 restrains melanoma growth by amplifying the reciprocal promotion of CXCL9 and IFN-gamma production in tumor microenvironment","volume":"37","author":"Xiao","year":"2018","journal-title":"Oncogene"},{"issue":"9","key":"2026100811084111400_cit18","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","article-title":"IFNgamma: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy","volume":"18","author":"Ivashkiv","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"2026100811084111400_cit19","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1158\/2159-8290.CD-21-0694","article-title":"PTP1B Is an Intracellular Checkpoint that Limits T cell and CAR T cell Antitumor Immunity","volume":"12","author":"Wiede","year":"2022","journal-title":"Cancer. Discov."},{"issue":"2","key":"2026100811084111400_cit20","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2019103637","article-title":"PTPN2 phosphatase deletion in T cells promotes anti-tumour immunity and CAR T cell efficacy in solid tumours","volume":"39","author":"Wiede","year":"2020","journal-title":"The EMBO journal"},{"issue":"10","key":"2026100811084111400_cit21","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1038\/s41590-019-0480-4","article-title":"PTPN2 regulates the generation of exhausted CD8(+) T cell subpopulations and restrains tumor immunity","volume":"20","author":"LaFleur","year":"2019","journal-title":"Nat. Immunol."},{"issue":"1","key":"2026100811084111400_cit22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140281","article-title":"Protein Tyrosine Phosphatase Nonreceptor Type 2 Controls Colorectal Cancer Development","volume":"131","author":"Katkeviciute","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"6","key":"2026100811084111400_cit23","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1438106","article-title":"Melanoma response to anti-PD-L1 immunotherapy requires JAK1 signaling, but not JAK2","volume":"7","author":"Luo","year":"2018","journal-title":"OncoImmunology"},{"issue":"9","key":"2026100811084111400_cit24","doi-asserted-by":"publisher","first-page":"10515","DOI":"10.1021\/acs.jmedchem.5c03738","article-title":"Discovery of Potent and Selective Benzothiophene Difluoromethyl Phosphonate (DFMP) PTPN2\/N1-Dual Inhibitors","volume":"69","author":"Zheng","year":"2026","journal-title":"J. Med. Chem."},{"key":"2026100811084111400_cit25","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.pharmthera.2017.02.027","article-title":"Targeted protein degradation by PROTACs","volume":"174","author":"Neklesa","year":"2017","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"2026100811084111400_cit26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.chembiol.2017.09.009","article-title":"The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study","volume":"25","author":"Burslem","year":"2018","journal-title":"Cell Chem. Biol."},{"issue":"1","key":"2026100811084111400_cit27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s42004-024-01263-7","article-title":"Mechanistic Insights into a Heterobifunctional Degrader-Induced PTPN2\/N1 Complex","volume":"7","author":"Hao","year":"2024","journal-title":"Commun. Chem."},{"issue":"3","key":"2026100811084111400_cit28","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1006\/bbrc.1995.2716","article-title":"Why Is Phosphonodifluoromethyl Phenylalanine a More Potent Inhibitory Moiety Than Phosphonomethyl Phenylalanine Toward Protein-Tyrosine Phosphatases","volume":"216","author":"Chen","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"44","key":"2026100811084111400_cit29","doi-asserted-by":"publisher","first-page":"12792","DOI":"10.1021\/bi035238p","article-title":"Cellular effects of small molecule PTP1B inhibitors on insulin signaling","volume":"42","author":"Xie","year":"2003","journal-title":"Biochemistry"},{"issue":"36","key":"2026100811084111400_cit30","doi-asserted-by":"publisher","first-page":"13072","DOI":"10.1021\/ja903733z","article-title":"Acquisition of a Potent and Selective TC-PTP Inhibitor via a Stepwise Fluorophore-Tagged Combinatorial Synthesis and Screening Strategy","volume":"131","author":"Zhang","year":"2009","journal-title":"J. Am. Chem. Soc."},{"issue":"43","key":"2026100811084111400_cit31","doi-asserted-by":"publisher","first-page":"18116","DOI":"10.1021\/ja308212y","article-title":"A highly selective and potent PTP-MEG2 inhibitor with therapeutic potential for type 2 diabetes","volume":"134","author":"Zhang","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"2026100811084111400_cit32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.coph.2021.02.009","article-title":"Transforming Targeted Cancer Therapy with PROTACs: A Forward-Looking Perspective","volume":"57","author":"Farnaby","year":"2021","journal-title":"Curr. Opin. Pharmacol."},{"issue":"4","key":"2026100811084111400_cit33","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41571-023-00736-3","article-title":"Protein Degraders Enter the Clinic \ue5f8 a New Approach to Cancer Therapy","volume":"20","author":"Chirnomas","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"2026100811084111400_cit34","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1039\/d4md00769g","article-title":"Property-based optimisation of PROTACs","volume":"16","author":"Scott","year":"2025","journal-title":"RSC Med. Chem."},{"issue":"11","key":"2026100811084111400_cit35","doi-asserted-by":"publisher","first-page":"7594","DOI":"10.1021\/acs.jmedchem.3c00493","article-title":"Design and Evaluation of a Low Hydrogen Bond Donor Count Fragment Screening Set to Aid Hit Generation of PROTACs Intended for Oral Delivery","volume":"66","author":"Whitehurst","year":"2023","journal-title":"J. Med. Chem."},{"issue":"13","key":"2026100811084111400_cit36","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.bmcl.2019.04.030","article-title":"Proteolysis targeting chimeras (PROTACs) in \u2019beyond rule-of-five\u2019 chemical space: Recent progress and future challenges","volume":"29","author":"Edmondson","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"12","key":"2026100811084111400_cit37","doi-asserted-by":"publisher","first-page":"8042","DOI":"10.1021\/acs.jmedchem.1c00482","article-title":"Unraveling the Role of Linker Design in Proteolysis Targeting Chimeras","volume":"64","author":"Bemis","year":"2021","journal-title":"J. Med. Chem."},{"issue":"34","key":"2026100811084111400_cit38","doi-asserted-by":"publisher","first-page":"21968","DOI":"10.1039\/d2ra03761k","article-title":"PROTACs bearing piperazine-containing linkers: what effect on their protonation state?","volume":"12","author":"Desantis","year":"2022","journal-title":"RSC Adv."},{"issue":"12","key":"2026100811084111400_cit39","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1016\/j.cell.2025.03.036","article-title":"CD36-Mediated Endocytosis of Proteolysis-Targeting Chimeras","volume":"188","author":"Wang","year":"2025","journal-title":"Cell"},{"issue":"6","key":"2026100811084111400_cit40","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/s0960-9822(02)00697-8","article-title":"The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3","volume":"12","author":"Simoncic","year":"2002","journal-title":"Curr. Biol."},{"issue":"16","key":"2026100811084111400_cit41","doi-asserted-by":"publisher","first-page":"5662","DOI":"10.1128\/MCB.22.16.5662-5668","article-title":"Identification of a nuclear Stat1 protein tyrosine phosphatase","volume":"22","author":"ten Hoeve","year":"2002","journal-title":"Mol. Cell. Biol."},{"issue":"5","key":"2026100811084111400_cit42","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.cmet.2011.09.011","article-title":"Elevated hypothalamic TCPTP in obesity contributes to cellular leptin resistance","volume":"14","author":"Loh","year":"2011","journal-title":"Cell Metab."},{"issue":"5","key":"2026100811084111400_cit43","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.4049\/jimmunol.1103458","article-title":"Phospholipase Cgamma2 plays a role in TCR signal transduction and T cell selection","volume":"189","author":"Fu","year":"2012","journal-title":"J. Immunol."},{"key":"2026100811084111400_cit44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fonc.2019.00151","article-title":"Preclinical Evaluation of Bispecific Adaptor Molecule Controlled Folate Receptor CAR-T Cell Therapy With Special Focus on Pediatric Malignancies","volume":"9","author":"Lu","year":"2019","journal-title":"Front. Oncol."},{"issue":"11","key":"2026100811084111400_cit45","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"2026100811084111400_cit46","doi-asserted-by":"publisher","first-page":"153723","DOI":"10.1016\/j.prp.2021.153723","article-title":"Cancer immunotherapy: Challenges and limitations","volume":"229","author":"Taefehshokr","year":"2022","journal-title":"Pathol., Res. Pract."},{"issue":"5","key":"2026100811084111400_cit47","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1039\/c8md90019a","article-title":"What are the drugs of the future?","volume":"9","author":"Ngo","year":"2018","journal-title":"MedChemComm"},{"issue":"6","key":"2026100811084111400_cit48","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1111\/bph.16304","article-title":"Protein Tyrosine Phosphatases as Emerging Targets for Cancer Immunotherapy","volume":"183","author":"Qu","year":"2026","journal-title":"British J. Pharmacology"},{"issue":"4","key":"2026100811084111400_cit49","doi-asserted-by":"publisher","first-page":"107957","DOI":"10.1016\/j.celrep.2020.107957","article-title":"PTPN2 Deficiency Enhances Programmed T Cell Expansion and Survival Capacity of Activated T Cells","volume":"32","author":"Flosbach","year":"2020","journal-title":"Cell Rep."},{"issue":"19","key":"2026100811084111400_cit50","doi-asserted-by":"publisher","first-page":"9094","DOI":"10.1021\/acs.jmedchem.6b00993","article-title":"Inhibition of Low Molecular Weight Protein Tyrosine Phosphatase by an Induced-Fit Mechanism","volume":"59","author":"He","year":"2016","journal-title":"J. Med. Chem."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.6c01484","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/19\/22336\/68606905\/jm6c01484.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/19\/22336\/68606905\/jm6c01484.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:03:11Z","timestamp":1791475391000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/69\/19\/22336\/5435740\/Discovery-and-Characterization-of-a-Cereblon-Based"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":50,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,9,22]]},"published-print":{"date-parts":[[2026,10,8]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c01484","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]}}}